APA (7th ed.) Citation

EM, J., S, M., K, H., D, N., B, B., A, D., . . . S, M. (2026). Robust CD4+ CAR T cell expansion is associated with non-ICANS neurotoxicities after ciltacabtagene autoleucel in patients with multiple myeloma. Science translational medicine, 18(860), eaed0039. https://doi.org/10.1126/scitranslmed.aed0039

Chicago Style (17th ed.) Citation

EM, Jurgens, et al. "Robust CD4+ CAR T Cell Expansion Is Associated with Non-ICANS Neurotoxicities After Ciltacabtagene Autoleucel in Patients with Multiple Myeloma." Science Translational Medicine 18, no. 860 (2026): eaed0039. https://doi.org/10.1126/scitranslmed.aed0039.

MLA (9th ed.) Citation

EM, Jurgens, et al. "Robust CD4+ CAR T Cell Expansion Is Associated with Non-ICANS Neurotoxicities After Ciltacabtagene Autoleucel in Patients with Multiple Myeloma." Science Translational Medicine, vol. 18, no. 860, 2026, p. eaed0039, https://doi.org/10.1126/scitranslmed.aed0039.